| The Acuity Trial | |
|
Principal Investigator: Jeffrey Schussler, M.D. Location: Baylor University Medical Center Sponsor: The Medicines Company. Inclusion Criteria: This is a trial looking at patients with acute coronary syndromes. The trial will look at which regimen of anticoagulation is best, including heparin, bivalirudin, and/or 2b-3a antagonists. Contact Information: Cathy Headley or Dr. Jeffrey Schussler (214.820.3192) |
|
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
